• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

TCT 2017: Medtronic touts results from 6-month Evolut Pro study
Medtronic (NYSE:MDT) today released six-month data from a study of its Evolut Pro transcatheter aortic valve replacement platform, touting low rates of paravalvular leaks and low rates of all-cause mortality and disabling stroke. Data came from 60 patients in the trial who received the Evolut Pro valve, and follow previously released 30-day outcomes. Results at six-months indicated trace or no paravalvular leaks in 88% of patients, with low rates of all-cause mortality and disabling stroke. No instances of coronary obstruction or valve thrombosis were reported and the permanent pacemaker implantation rate was 11.7%, Medt...
Source: Mass Device - November 2, 2017 Category: Medical Devices Authors: Fink Densford Tags: Catheters Clinical Trials Replacement Heart Valves Medtronic Source Type: news

Rapid Medical launches Tigertriever registry study
Neurovascular device maker Rapid Medical said it launched a registry study of its Tigertreiver controllable stent retriever. The Israel-based company touts the Tigertriever as the only controllable, fully-visible stent retriever which can be adjusted by the physician to fit in the dimensions of the blocked blood vessel. The newly launched European multi-center registry study looks to enroll patients in France and Switzerland, and will be the 1st to examine the use of the Tigertriever in a real-life setting. The company said it has enrolled its 1st patient in the trial at Switzerland’s Cantonal Hospital of Lucerne. ...
Source: Mass Device - September 19, 2017 Category: Medical Devices Authors: Fink Densford Tags: Catheters Clinical Trials Stents rapidmedical Source Type: news

Ariel Sharon showing brain activity seven years into comatose state
Former Israeli PM responding to external stimuli including son's voice and family pictures, say team of Israeli and US scientistsA team of Israeli and US scientists say new tests on comatose former Prime Minister Ariel Sharon show significant brain activity.Ben-Gurion University on Sunday said Sharon responded to external stimuli at Soroka Hospital in Beersheba.He was shown pictures of his family and listened to recordings of his son's voice while undergoing a special brain imaging scan. The university said "significant brain activity was observed ... indicating appropriate processing of these stimulations."However, Sharon...
Source: Guardian Unlimited Science - January 27, 2013 Category: Science Tags: Ariel Sharon United States Israel World news guardian.co.uk Medical research Coma Science Source Type: news

Pages: 1  2  3  4  5  6  7